BLIV vs INLX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a strong Current Ratio of 24.19 and moderate gross margin of 48.98%, the company is deeply unprofitable with an operating margin of -1507.43% and ROE of -109.04%. Revenue has collapsed by 54.20% year-over-year, and valuation multiples like Price/Sales of 22.48 are extremely high for a shrinking, unprofitable business. The stock has underperformed over the long term despite a short-term 6M gain, and peer comparisons show similar distressed profiles with no clear catalysts.
The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. Despite a strong gross margin of 66.05%, the business is struggling with stagnant revenue growth (1.00% YoY) and negative profitability (ROE -17.01%). The technical trend is completely bearish (0/100), and the stock has lost over 53% of its value in the last year. With a Forward P/E of 116.67 and no meaningful growth catalysts, the current valuation is difficult to justify.
Compare Another Pair
Related Comparisons
BLIV vs INLX: Head-to-Head Comparison
This page compares BeLive Holdings (BLIV) and Intellinetics, Inc. (INLX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.